Drugs

Threshold Pharmaceuticals and Merck KGaA, Darmstadt, Germany Agree to Key Terms for the Licensing Back of All Rights to Evofosfamide to Threshold

SOUTH SAN FRANCISCO, CA: ...

Boston Therapeutics'' sugardown(R) in Clinical Trials Reduces Glucose, Fructose and Insulin

NEWTON, MA: sugardown(R) Reduces Total Glycemic Index Including Fructose by up to 28 Percent and Insulin by up to 18 Percent ...

Knight Takes Right Angle With 60 Degrees Pharmaceuticals LLC

MONTREAL, CANADA: ...

Cadus Announces New Corporate Web-Site

NEW YORK, NY: ...

Vanc Pharmaceuticals Launches First OTC Product in British Columbia

VANCOUVER, BRITISH COLUMBIA: ...

Xylitol Canada Inc. Announces Termination of Brokered Private Placement

TORONTO, ONTARIO: ...

Cleveland BioLabs Announces Expanded U.S. Patent Protection for Entolimod

BUFFALO, NY: ...

GrowPros Appoints New Advisory Board Members, Stock Options Grant Clarification, and Provides Corporate Update

OTTAWA, ONTARIO: ...

Canadian Football League Brings Attention to Player Health Through Multi-Year Marketing Partnership With Monovisc(R)

TORONTO, ONTARIO: Pendopharm will provide knee-joint pain relief treatment to all CFL teams through 2017 ...

Aequus Receives Approval from Health Canada to Initiate Phase 1 Clinical Trial of Aripiprazole Transdermal Patch

VANCOUVER, BRITISH COLUMBIA: ...